Thu, Aug 21, 2014, 11:01 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Incyte Corporation Message Board

  • tjnelis tjnelis Jan 30, 2013 7:39 PM Flag

    jasoca, how come in you past messages, and your valuation you give to incyte

    does not count all human gene patients that incy owns, which is over half of them

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I've remarked on it in the distant past. Basically, I don't think natural gene patents are going to be worth much. The BRCA patents do a fine job of muddying the water for Myriad, but the courts seem close to deciding exactly what they can be used for, after which anyone who really wants to will have a guidebook for navigating around them. A lot of them are getting old, anyway.

      In principle, Incyte could collect little bits of royalties from many parties for research touching on their patented genes. That doesn't really work out because you need a way to prove infringement, and against a forewarned adversary that can be hard.

 
INCY
50.19-1.47(-2.85%)Aug 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.